| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2000;102:2799.)
© 2000 American Heart Association, Inc.
Brief Rapid Communication |
From the Section of Cardiac Surgery, Washington Hospital Center (S.C.S., A.J.P., M.K.C.D., P.J.C.), Washington, DC, and Cardiovascular Research Foundation (R.M., G.D., M.B.L.), New York, NY.
Correspondence to Roxana Mehran, MD, Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY, 10022. E-mail rmehran{at}crf.org
| Abstract |
|---|
|
|
|---|
Methods and ResultsWe followed all 274 patients who underwent MIDCAB from the time it was introduced at a single center. In-hospital and 1-year clinical events were source-documented and adjudicated. The in-hospital major acute cardiac event rate was 2.2%; this included a 1.1% mortality rate. At 1 year, the respective rates were 7.8% and 2.5%. When compared with the initial 100 procedures, the subsequent 174 procedures had shorter vessel occlusion times (10±5 versus 14±6 minutes; P=0.009), times to extubation (6±3 versus 14±10 hours; P<0.001), and lengths of hospital stay (2.1±1.9 versus 3.2±3.1 days; P=0.04). Cumulative 1-year adverse cardiac events were 11% in the initial 100 cases and 6% in the subsequent 174 cases (P=0.17).
ConclusionsExcellent clinical results can be achieved with the MIDCAB technique. The clinical adverse event rate may decrease with accumulated experience.
Key Words: coronary disease surgery grafting
| Introduction |
|---|
|
|
|---|
The purpose of the present study was to investigate early and late clinical outcomes after MIDCAB in a consecutive series of patients who were followed for 1 year after the procedure.
| Methods |
|---|
|
|
|---|
Major indications for MIDCAB included (1) isolated disease to the anterior descending or first diagonal artery; (2) multivessel disease in patients with significant concurrent medical illnesses for whom cardiopulmonary bypass posed a significant risk, such as patients with chronic renal failure, diffuse atherosclerosis of the ascending aorta, advanced age, or respiratory insufficiency8 ; and (3) patients who had religious convictions that precluded the use of blood products.
Hospital charts were prospectively reviewed, and patients were followed clinically for 1 year. Clinical events were source-documented and adjudicated. Data were recorded in the computerized database maintained by the Cardiovascular Research Foundation.
Statistical Analysis
Descriptive statistics were largely employed.
Comparisons were preformed between the initial 100 cases and the
subsequent 174 cases. Categorical variables were compared using
Fishers exact test. Continuous variables were expressed as mean±SD
and compared with Students t
test. P<0.05 was considered
significant. SPSS software 9.0 was
used.
| Results |
|---|
|
|
|---|
|
In-hospital results are presented in
Table 2
. Conversion to on-pump CABG was required in only 1
patient. No patient needed a conversion to off-pump CABG via median
sternotomy. Certain procedural variables seemed to improve with
accumulated experience.
|
The in-hospital major cardiac event rate was 2.2% (mortality rate, 1.1%). Angiograms for persistent postoperative chest pain were performed in 3 patients (1%) and showed a patent FitzGibbon grade A anastomosis.9
Clinical Outcome at 1 Year
At 1 year, the cumulative rates of major adverse
cardiac events and mortality were 7.8% and 2.5%, respectively
(Table 3
). Adverse cardiac events rates at 1 year were 11%
in the initial 100 cases and 6% in the subsequent 174 cases
(P=0.17).
|
Causes of death in the initial 100-case subset were acute myocardial infarction (n=2), stroke (n=1), and ruptured aortic aneurysm (n=1). Causes of death in the subsequent 174-case subset were acute myocardial infarction (n=1) and myocardial failure during emergent CABG (n=1). The latter death occurred in a patient who developed acute occlusion of the left main artery and underwent emergent percutaneous transluminal coronary angioplasty and subsequent CABG 1 year after MIDCAB.
In the year after surgery, none of the patients who had angiographic follow-up showed a restenosed (>50% diameter stenosis) arterial bypass conduit.
| Discussion |
|---|
|
|
|---|
In the present study, we present the 1-year follow-up results of the first 274 MIDCAB cases. One-year clinical events were low, and there was a slight tendency for the event rate to improve with accumulated technical experience.
MIDCAB for reoperative bypass surgery was less frequent in the initial than in the subsequent phase of this study. Recent reports suggest that redo-CABG patients have better outcomes with off-pump than with on-pump CABG surgery.14 15 Avoidance of cardiopulmonary bypass has been associated with decreased rates of postoperative platelet dysfunction and systemic stress from inflammation.16 Over-manipulation of the atheromatous aorta may result in a significantly increased risk of stroke after conventional on-pump CABG.16 Not only does MIDCAB eliminate cardiopulmonary bypass, but it also obviates the need for aortic manipulation.
Postoperative pain management is crucial for successful early extubation. Because MIDCAB has been associated with significant pain during the early postoperative period,17 a more aggressive pain management protocol was adopted in our institution to allow for early extubation, minimize patient discomfort, expedite recovery, and permit early ambulation. In addition to improved pain control, the very low rate of postoperative atrial fibrillation may explain the short length of hospital stay after MIDCAB.18
Perioperative Outcome
Berger et
al13 recently reported the
early in-hospital patency rate of LIMA-to-LAD anastomosis without a
stenosis >50% to be 91% after conventional on-pump CABG. In the
present study, despite the absence of angiographic follow-up, the
uneventful in-hospital recovery of >99% of the entire cohort seems
encouraging for the MIDCAB operation. This is very close to the
reported 98% in-hospital patency rate (with possible obstructive
stenosis) of LIMA-to-LAD anastomosis after conventional on-pump
CABG.13
Outcome at 1 Year
A recent report indicated an excellent graft patency
rate of LIMA-to-LAD anastomosis after
MIDCAB19 : early and 6-mont
patency rates were 97% and 95%, respectively, with a 3%
reintervention rate. Despite the absence of early or late angiographic
confirmation of patency in this study, the low repeat revascularization
rate supports the safety of MIDCAB as a surgical option for the
treatment of coronary artery disease.
We documented a 1-year reintervention rate of 2.9% and a 1-year actuarial survival rate of 98%. These values were statistically similar between the initial 100 cases and the subsequent 174 cases, although mortality was arithmetically higher in the former group. This small but encouraging improvement in survival rate, as well as the durability of the anastomosis during the course of the study, likely reflects the importance of the learning curve in the long-term clinical outcome of patients after MIDCAB.
Limitations
This was a retrospective study without angiographic
follow-up. However, chart review, data entry, and adjudication of
cardiac events were independently performed according to prespecified
definitions. Multivariate analysis was not performed because of the
very low total number of major events.
Conclusions
Excellent clinical results can be achieved with the
MIDCAB technique. The clinical adverse event rate may decrease with
accumulated
experience.
| Footnotes |
|---|
Received August 25, 2000; revision received September 29, 2000; accepted October 8, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
V. Falk and F. W. Mohr Minimally Invasive Myocardial Revascularization Card. Surg. Adult, January 1, 2008; 3(2008): 697 - 710. [Full Text] |
||||
![]() |
D. M. Holzhey, S. Jacobs, M. Mochalski, T. Walther, H. Thiele, F. W. Mohr, and V. Falk Seven-Year Follow-up After Minimally Invasive Direct Coronary Artery Bypass: Experience With More Than 1300 Patients Ann. Thorac. Surg., January 1, 2007; 83(1): 108 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Marx, G. Kalweit, U. Sunderdiek, T. W. Jax, R. M. Klein, S. Szabo, H. M. Hoffmeister, and H. Gulker Stress Doppler echocardiography of the internal thoracic artery - a new non-invasive approach for functional assessment after minimally invasive coronary bypass grafting Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 584 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dangas, S. G. Ellis, R. Shlofmitz, S. Katz, D. Fish, S. Martin, R. Mehran, M. E. Russell, G. W. Stone, and TAXUS-IV Investigators Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1186 - 1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lichtenberg, U. Klima, H. Paeschke, M. Pichlmaier, S. Ringes-Lichtenberg, T. Walles, H. Goerler, and A. Haverich Impact of diabetes on outcome following isolated minimally invasive bypass grafting of the left anterior descending artery Ann. Thorac. Surg., July 1, 2004; 78(1): 129 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zimarino, S. Gallina, M. Di Fulvio, M. Di Mauro, G. Di Giammarco, R. De Caterina, and A. M. Calafiore Intraoperative ischemia and long-term events after minimally invasive coronary surgery Ann. Thorac. Surg., July 1, 2004; 78(1): 135 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Izutani and I. S. Gill Acute graft failure caused by an intracoronary shunt in minimally invasive direct coronary artery bypass grafting J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 723 - 724. [Full Text] [PDF] |
||||
![]() |
S. Fraund, H. Behnke, A. Boening, and J. Cremer Immediate postoperative extubation after minimally invasive direct coronary artery surgery (MIDCAB) Interactive CardioVascular and Thoracic Surgery, September 1, 2002; 1(1): 41 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Suematsu, S. Takamoto, and T. Ohtsuka Intraoperative echocardiographic imaging of coronary arteries and graft anastomoses during coronary artery bypass grafting without cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1147 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.B. Anderson, K.F. Kwong, A.J. Furst, and T.A. Salerno Thoracic epidural anesthesia for coronary bypass via left anterior thoracotomy in the conscious patient Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 415 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Stamou and P. J. Corso Coronary revascularization without cardiopulmonary bypass in high-risk patients: a route to the future Ann. Thorac. Surg., March 1, 2001; 71(3): 1056 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
Good Outcomes with Minimally Invasive CABG Journal Watch (General), December 29, 2000; 2000(1229): 2 - 2. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |